AUPH (STOCKS)
Aurinia Pharmaceuticals Inc
$16.190700
+0.430700 (+2.73%)
Prev close: $15.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kevin C. Tang
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,134.32M
- Employees
- 300
- P/E (TTM)
- 7.61
- P/B (TTM)
- 3.59
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $283.06M |
| Benefits Costs and Expenses | $168.90M |
| Cost Of Revenue | $32.67M |
| Costs And Expenses | $178.14M |
| Gross Profit | $250.39M |
| Operating Expenses | $178.14M |
| Research and Development | $32.51M |
| Other Operating Expenses | $145.64M |
| Operating Income/Loss | $104.91M |
| Income/Loss From Continuing Operations After Tax | $287.20M |
| Income/Loss From Continuing Operations Before Tax | $114.16M |
| Income Tax Expense/Benefit | -$173.05M |
| Income Tax Expense/Benefit, Current | $3.15M |
| Income Tax Expense/Benefit, Deferred | -$176.19M |
| Net Income/Loss | $287.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $287.20M |
| Net Income/Loss Available To Common Stockholders, Basic | $287.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.14 |
| Diluted Earnings Per Share | $2.07 |
| Basic Average Shares | 134,367,000 |
| Diluted Average Shares | 138,700,000 |
| Assets | $751.59M |
| Current Assets | $491.97M |
| Inventory | $45.69M |
| Other Current Assets | $446.28M |
| Noncurrent Assets | $259.62M |
| Fixed Assets | $2.11M |
| Other Non-current Assets | $257.51M |
| Liabilities | $170.26M |
| Current Liabilities | $93.72M |
| Accounts Payable | $3.31M |
| Wages | $18.72M |
| Other Current Liabilities | $71.70M |
| Noncurrent Liabilities | $76.53M |
| Equity | $581.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $581.33M |
| Liabilities And Equity | $751.59M |
| Net Cash Flow From Operating Activities | $135.66M |
| Net Cash Flow From Operating Activities, Continuing | $135.66M |
| Net Cash Flow From Investing Activities | -$32.77M |
| Net Cash Flow From Investing Activities, Continuing | -$32.77M |
| Net Cash Flow From Financing Activities | -$106.11M |
| Net Cash Flow From Financing Activities, Continuing | -$106.11M |
| Net Cash Flow | -$3.22M |
| Net Cash Flow, Continuing | -$3.22M |
| Comprehensive Income/Loss | $287.25M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $287.25M |
| Other Comprehensive Income/Loss | $287.25M |